Formac Pharmaceuticals signs feasibility agreement with major generic drug company

23 May 2012 – Formac Pharmaceuticals signs feasibility agreement with major generic drug company

Formac's mesoporous silica based drug delivery platform will be evaluated for the reformulation of a blockbuster drug. This agreement forms an important expansion of the activities of Formac that were to date centered around the formulation of new chemical entities.